These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14973528)

  • 1. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study.
    Safarinejad MR
    Int J Impot Res; 2004 Jun; 16(3):238-43. PubMed ID: 14973528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.
    Safarinejad MR; Asgari MA; Hosseini SY; Dadkhah F
    BJU Int; 2010 Jul; 106(2):240-8. PubMed ID: 19863517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with intraplaque injection of verapamil for Peyronie's disease.
    Levine LA; Goldman KE; Greenfield JM
    J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
    Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
    BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease.
    Prieto Castro RM; Leva Vallejo ME; Regueiro Lopez JC; Anglada Curado FJ; Alvarez Kindelan J; Requena Tapia MJ
    BJU Int; 2003 Apr; 91(6):522-4. PubMed ID: 12656907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is colchicine effective in Peyronie's disease? A pilot study.
    Akkus E; Carrier S; Rehman J; Breza J; Kadioglu A; Lue TF
    Urology; 1994 Aug; 44(2):291-5. PubMed ID: 8048212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen versus placebo in the treatment of Peyronie's disease.
    Teloken C; Rhoden EL; Grazziotin TM; Ros CT; Sogari PR; Souto CA
    J Urol; 1999 Dec; 162(6):2003-5. PubMed ID: 10569556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
    Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
    J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies.
    Hellstrom WJ; Feldman RA; Coyne KS; Kaufman GJ; Smith TM; Tursi JP; Rosen RC
    Urology; 2015 Aug; 86(2):291-8. PubMed ID: 26199168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome.
    Kadioglu A; Tefekli A; Köksal T; Usta M; Erol H
    Int J Impot Res; 2000 Jun; 12(3):169-75. PubMed ID: 11045911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.
    Gennaro R; Barletta D; Paulis G
    Int Urol Nephrol; 2015 Oct; 47(10):1595-602. PubMed ID: 26257044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study.
    Weidner W; Hauck EW; Schnitker J;
    Eur Urol; 2005 Apr; 47(4):530-5; discussion 535-6. PubMed ID: 15774254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
    Serefoglu EC; Smith TM; Kaufman GJ; Liu G; Yafi FA; Hellstrom WJG
    Urology; 2017 Sep; 107():155-160. PubMed ID: 28554517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
    Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
    J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
    Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
    J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
    Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
    South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.